Vitadio is pioneering prescription digital therapeutics focused on reversing insulin resistance through AI-driven lifestyle modification. Their mission empowers people to restore their cardiometabolic health by creating digital therapies that treat the cause of chronic conditions such as type 2 diabetes and prediabetes.

Vitadio developed the first digital therapy for type 2 diabetes covered by all statutory health insurers in Germany. Their product is a Class I medical device under MDR, ISO 27001 and GDPR compliant, developed by healthcare professionals. They provide personalized therapy using smart nudges and evidence-based content combined with complex user data, AI-driven real-time diet feedback, and proactive human support.

Vitadio is committed to rigorous validation through clinical studies showing significant benefits in diabetes management, including superior reduction in HbA1c, weight reduction, and better quality of life. Their digital therapeutics platform is proven to have exceptional engagement rates with users, comparable to established social media platforms.

Founded in 2019 by four founders in Prague and Berlin, Vitadio continues to expand its digital therapeutics offerings across Europe. The company combines artificial intelligence and evidence-based medicine to innovate type 2 diabetes care.

Vitadio is actively hiring for their purpose-driven team. Contact information includes [email protected] for general inquiries and [email protected] for career inquiries. Their LinkedIn page is https://www.linkedin.com/company/vitadio/.